Adelbert L. Stagg

General Counsel at AEON Biopharma Sub, Inc.

77 year

Finance

Health Technology

Profile

Adelbert L.
Stagg is currently the VP-Development, Technical Operations & Regulatory at AEON Biopharma Sub, Inc. He previously worked as the Vice President-Regulatory Affairs & Quality at Artes Medical, Inc. from 2005 to 2007.

Adelbert L. Stagg active positions

Companies	Position	Start
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	General Counsel	31/05/2019

All active positions of Adelbert L. Stagg

Former positions of Adelbert L. Stagg

Companies	Position	End
Artes Medical, Inc. Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA.	General Counsel	31/08/2007

See the detail of Adelbert L. Stagg's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adelbert L. Stagg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Artes Medical, Inc. Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA.	Finance
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Health Technology